License Agreements

9,337 Contracts & Agreements

License agreements define rights and other benefits for the licensing of intellectual property.

Browse License Agreements by Industry

Aerospace & Defense (21 contracts from 9 companies)
Air Freight & Logistics (7 | 3)
Airlines (4 | 2)
Auto Components (9 | 8)
Automobiles (7 | 5)
Banks (10 | 8)
Beverages (11 | 3)
Biotechnology (2,851 | 516)
Building Products (8 | 5)
Capital Markets (185 | 18)
Chemicals (63 | 23)
Commercial Services & Supplies (39 | 18)
Communications Equipment (19 | 14)
Construction & Engineering (7 | 2)
Consumer Finance (8 | 6)
Containers & Packaging (7 | 2)
Distributors (3 | 2)
Diversified Consumer Services (24 | 6)
Diversified Financial Services (8 | 6)
Diversified Telecommunication Services (8 | 6)
Electric Utilities (10 | 5)
Electrical Equipment (32 | 12)
Electronic Equipment, Instruments & Components (41 | 18)
Energy Equipment & Services (72 | 38)
Entertainment (69 | 13)
Equity Real Estate Investment Trusts (REITs) (12 | 7)
ETFs (83 | 47)
Food Products (48 | 20)
Food & Staples Retailing (5 | 3)
Gas Utilities (1 | 1)
Health Care Equipment & Supplies (628 | 171)
Health Care Providers & Services (208 | 76)
Health Care Technology (28 | 16)
Hotels, Restaurants & Leisure (74 | 33)
Household Durables (35 | 12)
Household Products (1 | 1)
Independent Power & Renewable Electricity Producers (1 | 1)
Industrial Conglomerates (3 | 2)
Insurance (8 | 8)
Interactive Media & Services (27 | 16)
Internet & Direct Marketing Retail (16 | 10)
IT Services (36 | 15)
Leisure Products (11 | 7)
Life Sciences Tools & Services (157 | 26)
Machinery (12 | 8)
Media (66 | 17)
Metals & Mining (42 | 17)
Multiline Retail (1 | 1)
Oil, Gas & Consumable Fuels (81 | 31)
Paper & Forest Products (4 | 1)
Personal Products (59 | 24)
Pharmaceuticals (1,201 | 269)
Professional Services (17 | 10)
Real Estate Management & Development (4 | 3)
Semiconductors & Semiconductor Equipment (91 | 34)
Software (197 | 57)
SPACs, Investment, & Acquisition Companies (115 | 42)
Specialty Retail (14 | 9)
Technology Hardware, Storage & Peripherals (26 | 10)
Textiles, Apparel & Luxury Goods (42 | 11)
Thrifts & Mortgage Finance (2 | 1)
Tobacco (8 | 2)
Trading Companies & Distributors (1 | 1)
Transportation Infrastructure (1 | 1)
Water Utilities (4 | 3)
Wireless Telecommunication Services (10 | 4)
Unassigned Industry (2,433 | 946)

Recent Contracts

License Agreement, dated as of April 12, 2024, between the Company and BARC (TOCA) LIMITED (MOTORSPORT GAMING US LLC, Filed With SEC on April 18, 2024)
Royalty Bearing Manufacturing License between AST & Science, LLC and the Company, dated March 6, 2024 (Holicity Inc., Filed With SEC on April 18, 2024)
License Agreement with The Regents of the University of California (Invizyne Technologies Inc, Filed With SEC on April 17, 2024)
Definitive License Agreement between Rgene and OncoX BioPharma, Inc (American BriVision (Holding) Corp, Filed With SEC on April 17, 2024)
Definitive License Agreement between the Company and OncoX BioPharma, Inc (American BriVision (Holding) Corp, Filed With SEC on April 17, 2024)
License, Development and Commercialization Agreement, by and between the Company and Lees Pharmaceutical (HK) Ltd., dated January 12, 2024 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
Amendment No. 1, effective as of January 17, 2024, to the License Agreement, between Windtree and Philip Morris Products S.A. dated March 28, 2008 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
Amendment No. 1, effective as of January 17, 2024, to the Amended and Restated License Agreement, between Windtree and Philip Morris USA Inc. dated March 28, 2008 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
Amendment No. 1 to the License and Distribution Agreement, dated December 29, 2023, by and between the Company and Nuwellis, Inc (LMF Acquisition Opportunities Inc, Filed With SEC on April 16, 2024)
Second Amendment to the Exclusive License Agreement by and between the Registrant and The Washington University, dated as of November 28, 2023 (HISTOGENICS CORP, Filed With SEC on April 16, 2024)
Seventh Amendment to Exclusive License Agreements (BROWN ID 2465, 2576, 2587, BROWN ID 3039, BROWN ID 2613, BROWN ID 2502) between Elkurt Inc. and Ocean Biomedical, Inc. (n/k/a... (Aesther Healthcare Acquisition Corp., Filed With SEC on April 15, 2024)
Sustainable Oils License Agreement, dated as of April 9, 2024, by and between Sustainable Oils, Inc. and Bakersfield Renewable Fuels, LLC (Global Clean Energy Holdings, Inc., Filed With SEC on April 12, 2024)
Technology License and Distribution Agreement, dated October 30, 2015, between the Registrant, as (Silvaco Group, Inc., Filed With SEC on April 12, 2024)
License Agreement, dated March 27, 2023, between Proteomedix and Laboratory Corporation of America Holdings (Blue Water Vaccines Inc., Filed With SEC on April 11, 2024)
Amendment No. 3, dated February 11, 2024, to the First License Agreement, dated May 28, 2020, by and between LEXEO Therapeutics, Inc. and Cornell University (as amended by... (Lexeo Therapeutics, Inc., Filed With SEC on April 9, 2024)
Amended and Restated Intellectual Property License Agreement with Premier Anti-Aging Co., Ltd. dated March 15, 2024 (Lexaria Bioscience Corp., Filed With SEC on April 9, 2024)
Data Use and License Agreement, dated April 3, 2024, by and between QT Imaging Center and QT Imaging Holdings, Inc (GigCapital5, Inc., Filed With SEC on April 8, 2024)
First Amendment to License Agreements (Comstock Mining Inc., Filed With SEC on April 8, 2024)
Intellectual Property Cross License Agreement, dated as of March 31, 2024, by and between 3M Company and Solventum Corporation (3M, Filed With SEC on April 4, 2024)
Intellectual Property Cross License Agreement, dated as of March 31, 2024, by and between 3M Company and Solventum Corporation (Solventum Corp, Filed With SEC on April 4, 2024)
License Modification 1, dated August 31, 2022, to Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Non-Exclusive License Agreement by and between Adaptive Phage Therapeutics, Inc. and Walter Reed Army Institute of Research, dated August 24, 2021 (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
First Amendment, dated January 10, 2019, to Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Exclusive License between Adaptive Phage Therapeutics, Inc. and United States of America, as represented by the Secretary of the Navy, dated March 16, 2017 (Chardan Healthcare Acquisition Corp., Filed With SEC on April 4, 2024)
Amendment to Technology License and Commercialization Agreement between Recruiter.com Group, Inc. and GoLogiq, Inc., dated March 28, 2024 (LOVARRA, Filed With SEC on April 3, 2024)
Third Amendment to License and Supply Agreement, dated April 24, 2023, by and between Daewoong Pharmaceutical Co (Priveterra Acquisition Corp., Filed With SEC on April 2, 2024)
Second Amendment to the License and Supply Agreement, dated as of January 8, 2023, by and between AEON Biopharma, Inc. and Daewoong Pharmaceutical Co., Ltd (Priveterra Acquisition Corp., Filed With SEC on April 2, 2024)
Amendment to Technology License and Commercialization Agreement with GoLogiq, Inc (TRULI TECHNOLOGIES, INC., Filed With SEC on April 2, 2024)
License Agreement between Aspira Womens Health Inc. and Dana-Farber Cancer Institute, Inc. effective March 20, 2023 (VERMILLION, INC., Filed With SEC on April 1, 2024)
Clyra Medical Technologies, Inc. license to BioLargo dated March 1, 2024 (BIOLARGO, INC., Filed With SEC on April 1, 2024)
BioLargo license to Clyra Medical Technologies, Inc., dated March 1, 2024 (BIOLARGO, INC., Filed With SEC on April 1, 2024)
License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Zomedica Pharmaceuticals Corp., Filed With SEC on April 1, 2024)
Second Amendment to Exclusive License Agreement, dated November 3, 2022, by and between Genprex, Inc. and the University of Pittsburgh - Of the Commonwealth System of Higher... (Genprex, Inc., Filed With SEC on April 1, 2024)
Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd (OMEROS CORP, Filed With SEC on April 1, 2024)
Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd (OMEROS CORP, Filed With SEC on April 1, 2024)
License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010 (OMEROS CORP, Filed With SEC on April 1, 2024)
License Agreement, by and between Perspective Therapeutics, Inc. and Mayo Foundation for Medical Education and Research, dated December 31, 2023 (Isoray, Inc., Filed With SEC on March 28, 2024)
Letter Agreement re License Agreement between Flagship Pioneering Innovations V, Inc. and the Registrant dated December 31, 2023 relating to the License Agreement dated March 12,... (Omega Therapeutics, Inc., Filed With SEC on March 28, 2024)
Amendment No. 2 to the Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated March 13, 2024 (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
Certain confidential information contained in this document, marked by brackets, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K. SEVENTH AMENDMENT TO SOFTWARE... (Pivotal Acquisition Corp, Filed With SEC on March 28, 2024)